PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6966826

Iododerma complicating cardiovascular surgery.

L R Willams·R L Rietschel
View original source ↗Export metadata ↓

Abstract

A patient had cardiovascular surgery and received pericardial povidone-iodine irrigation along with extensive topical povidone-iodine. A postoperative febrile response occurred and persisted despite antibiotic therapy. Within 24 hours of the administration of oral potassium iodide, a pustular iododerma occurred. Discontinuation of oral and topical iodine resulted in defervescence of fever and resolution of the cutaneous eruption.

Explore related subjects

Coronary Artery BypassHumansMaleMiddle AgedPostoperative ComplicationsPovidonePovidone-IodineSkin DiseasesCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L R Willams, R L Rietschel. 1980. Iododerma complicating cardiovascular surgery.. https://doi.org/10.1097/00007611-198007000-00033

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

Enrollment in the Health Alliance Plan HMO is not an independent risk factor for coronary artery bypass graft surgery.

BACKGROUND: Henry Ford Hospital is the sole provider of cardiac surgical services for the Health Alliance Plan, a health maintenance organization (HMO) that presently serves 450,000 enrollees. METHODS AND RESULTS: To determine the effect of managed care referral patterns on the outcome of coronary artery bypass graft (CABG) surgery, we retrospectively reviewed two concurrent groups of patients, 569 HMO patients and 225 patients with free-for-service (FFS) insurance, who had undergone isolated primary CABG surgery between January 1, 1990 and January 31, 1994. The 605 patients with Medicare operated on during the same time frame were excluded to obviate age bias. Age, sex, use of cardiac medications, history of prior percutaneous transluminal coronary angioplasty or thrombolytic therapy, history of recent and remote myocardial infarction, extent of coronary disease, presence of preexisting comorbid conditions, and incidence of unstable clinical syndromes and left ventricular dysfunction (ejection fraction < 40%) were comparable for both groups. In hospital mortality (HMO group, 1.9%; FFS group, 2.2%), mean ICU stay (HMO, 2.6 +/- 0.3 days; FFS, 2.3 +/- 0.3 days), and total hospital length of stay (HMO, 9.8 +/- 0.8 days; FFS, 8.6 +/- 0.6 days) were likewise similar. CONCLUSIONS: These data refute the notion that the gate-keeper mentality often associated with managed-care health insurance vehicles results in delayed referral of patients with coronary artery disease and results in suboptimal outcome.

Coronary Artery Bypass↗